Hamilton Thorne logo

HTL - Hamilton Thorne Share Price

C$1.74 -0.0  -0.6%

Last Trade - 13/04/21

Small Cap
Market Cap £140.8m
Enterprise Value £132.4m
Revenue £29.0m
Position in Universe 605th / 2712
Unlock HTL Revenue
Relative Strength (%)
1m +6.49%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -4.89%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
9.03 10.5 22.1 29.2 35.4 39.8 45.3 50.6 +34.5%
-0.5 -39.4 +478.2 -54.0 -65.4 -16.8 +216.5 +50.0
Balance Sheet
FINANCIAL BRIEF: : For the fiscal year ended 31 December 2020, HamiltonThorne Ltd revenues increased 12% to $39.8M. Net incomeincreased 22% to $971K. Revenues reflect an increase indemand for the Company's products and services due tofavorable market conditions. Net income benefited fromForeign exchange loss decrease of 72% to $8K (expense).Basic Earnings per Share excluding Extraordinary Itemsremained flat at $0.01.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for HTL
Graphical History


HTL Revenue Unlock HTL Revenue

Net Income

HTL Net Income Unlock HTL Revenue

Normalised EPS

HTL Normalised EPS Unlock HTL Revenue

PE Ratio Range

HTL PE Ratio Range Unlock HTL Revenue

Dividend Yield Range

HTL Dividend Yield Range Unlock HTL Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
HTL EPS Forecasts Unlock HTL Revenue
Profile Summary

Hamilton Thorne Ltd. is engaged in the development, manufacture and sale of precision laser devices and advanced image analysis systems for living cell applications in the fertility, stem cell and developmental biology research markets. The Company offers Clinical lasers, Research lasers and Clinical Sperm Analysis Products. Its Clinical lasers include LYKOS laser and ZILOS-tk laser for applications, such as laser-assisted hatching and embryo biopsy for pre-implantation genetic diagnosis (PGD). Its Research lasers include XYRCOS laser, XYClone laser and Stiletto laser for applications, such as transgenic animal production, stem cell applications and somatic cell nuclear transfer. Its Clinical Sperm Analysis Products include IVOS II Clinical, CEROS II Clinical and Dimensions II Strict Morphology for applications, such as fertility testing, reproductive toxicology, and biological research. It also provides ZANDAIR air purification systems for in-vitro fertilization and pathology.

Last Annual December 31st, 2020
Last Interim December 31st, 2020
Incorporated February 19, 2007
Public Since July 10, 2007
No. of Shareholders: n/a
No. of Employees: n/a
Sector Healthcare
Industry Healthcare Equipment & Supplies
Exchange TSX Venture Exchange
Shares in Issue 138,898,639
Free Float (0.0%)
Eligible for
HTL Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for HTL
Upcoming Events for HTL
Frequently Asked Questions for Hamilton Thorne
What is the Hamilton Thorne share price?

As of 13/04/21, shares in Hamilton Thorne are trading at C$1.74, giving the company a market capitalisation of £140.8m. This share price information is delayed by 15 minutes.

How has the Hamilton Thorne share price performed this year?

Shares in Hamilton Thorne are currently trading at C$1.74 and the price has moved by 66.67% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Hamilton Thorne price has moved by 22.01% over the past year.

What are the analyst and broker recommendations for Hamilton Thorne?

Of the analysts with advisory recommendations for Hamilton Thorne, there are there are currently 2 "buy" , 0 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Hamilton Thorne is Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will Hamilton Thorne next release its financial results?

Hamilton Thorne is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the Hamilton Thorne dividend yield?

Hamilton Thorne does not currently pay a dividend.

Does Hamilton Thorne pay a dividend?

Hamilton Thorne does not currently pay a dividend.

When does Hamilton Thorne next pay dividends?

Hamilton Thorne does not currently pay a dividend.

How do I buy Hamilton Thorne shares?

To buy shares in Hamilton Thorne you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Hamilton Thorne?

Shares in Hamilton Thorne are currently trading at C$1.74, giving the company a market capitalisation of £140.8m.

Where are Hamilton Thorne shares listed? Where are Hamilton Thorne shares listed?

Here are the trading details for Hamilton Thorne:

Country of listing: Canada
Exchange: CVE
Ticker Symbol: HTL
What kind of share is Hamilton Thorne?

Based on an overall assessment of its quality, value and momentum, Hamilton Thorne is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Hamilton Thorne share price forecast 2021?

Shares in Hamilton Thorne are currently priced at C$1.74. At that level they are trading at 15.56% discount to the analyst consensus target price of 0.00.

Analysts covering Hamilton Thorne currently have a consensus Earnings Per Share (EPS) forecast of 0.022 for the next financial year.

How can I tell whether the Hamilton Thorne share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Hamilton Thorne. Over the past six months, the relative strength of its shares against the market has been 9.62%. At the current price of C$1.74, shares in Hamilton Thorne are trading at 23.8% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Hamilton Thorne PE Ratio?

The Hamilton Thorne PE ratio based on its reported earnings over the past 12 months is 0.200k. The shares are currently trading at C$1.74.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Hamilton Thorne?

Hamilton Thorne's management team is headed by:

Bruno Maruzzo - IND
Meg Spencer - CHM
Diarmaid Douglas-Hamilton - SVP
Robert Potter - IND
David Wolf - PRE
Michael Bruns - CFO
David Sable - DRC
Thomas Kenny - VPR
Keith Edwards - SVP
Fabian Sell - CEO
Marc Robinson - IND
Feng Han - IND
Who are the major shareholders of Hamilton Thorne?

Here are the top five shareholders of Hamilton Thorne based on the size of their shareholding:

Thorne (Daniel K) Individual Investor
Percentage owned: 14.49% (20.1m shares)
FAX Investments, Inc. Corporation
Percentage owned: 11.45% (15.9m shares)
AWM Investment Company, Inc. Investment Advisor/Hedge Fund
Percentage owned: 10.09% (14.0m shares)
Norrep Capital Management Ltd. Investment Advisor
Percentage owned: 3.34% (4.64m shares)
Norrep II Class Mutual Fund
Percentage owned: 2.36% (3.28m shares)
Similar to HTL
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.